Skip to main content
The William Harvey Research Institute - Faculty of Medicine and Dentistry

Cardiovascular Seminar Series

This online series will take place on Thursdays from 4-5pm. 

If you would like to sign up to present or need any further information please contact m.anbeek@qmul.ac.uk 

Past Seminars

12th January

Dr Katja Gehmlich (University of Birmingham)

The role of Z-disc proteins in cardiomyopathy

 

9th February

Professor Tomasz Guzik (University of Edinburgh)

Targeting inflammation in hypertension and associated vascular dysfunction

 

23rd February

Dr Aleksandar Ivetic (King's College London)

Endothelial cell permeability: from a novel mechanism to a druggable target

 

9th March

Professor Iain Scott (University of Pittsburgh)

Dysregulated mitochondrial lysine acetylation in cardiometabolic disease

 

23rd March

Professor Damian Tyler (University of Oxford)

Hyperpolarized magnetic resonance imaging - A novel technique to assess cardiac metabolism

 

4th May

Professor Costantino Iadecola (Feil Family Brain and Mind Research Institute)

Neurovascular determinants of brain health: bench to bedside

 

18th May

Professor Albert van der Vliet (University of Vermont)

DUOX1 in lung remodeling during chronic lung disease. A unique role in macrophages

 

1st June

Dr Ketaki Mhatre (University of Washington)

Functional and metabolic benefits of deoxy ATP cell therapy against chronic heart failure

 

22nd June

Professor Lea Delbridge (University of Melbourne)

Heart failure with preserved ejection fraction...is there something special about women?

 

29th June

Dr Chi Fung Lee (OMRF)

Mitochondrial and NAD metabolism in cardiometabolic disease

 

27th July

Dr Melanie Madhani (University of Birmingham)

Role of nitrite and persulfides in cardiovascular health and disease

 

7th September

Dr Evan DeVallance (West Virginia University)

Redox-mediated epigenetics in the vasculature following toxicant inhalation: Role of endothelial bound xanthine oxidase

 

21st September

Dr Javier Barallobre Barreiro (King's College London)

The landscape of human heart failure; studying the effect of mutations, medications and comorbidities

 

5th October

Dr George Robinson (UCL)

Lipid metabolism and inflammation in juvenile lupus: mechanisms of early atherosclerosis 

 

12th October

Professor Paul Evans (QMUL)

Endothelial responses to stress in atherosclerosis 

 

2nd November 

Heartfelt stories: why public engagement and involvement matters

 

30th November

Dr Oleksandra Prysyazhna (QMUL)

Blood pressure is regulated by RSK1/2 redox state - opportunities for a new class of anti-hypertensives

 

11th January

Professor Laurent Yvan-Charvet (INSERM, France)

Artery wall remodelling by local and distal glutamine metabolism 

 

18th January

Professor Steven Niederer (Imperial College)

A multi-scale patient-specific modelling approach to cardiac physiology, pathology and care

 

25th January

Dr Alessandra Ghigo (University of Turin)

Transcriptional and metabolic adaptations to cardiotoxic anticancer therapies

 

8th February

Dr Jan Dudek (University Clinic Wurzburg)

Activation of the integrated stress response rewires cardiac metabolism in Barth Syndrome

 

15th February

Dr Jan Miljkovic (University of Cambridge)

Chemical biology of H2S and implication of cross-talk with NO cardiovascular physiology

 

7th March

Dr Sarah Schumacher (Cleveland Clinic Lerner College of Medicine)

Cardiac GRK2 peptide as a tool to understand sexual dimorphism in heart failure and cardiometabolism

 

14th March

Dr Florian Weinberger (CNIC)

Pluripotent stem cell derived cardiomyocytes for cardiac repair - pharmacological considerations

 

21st March

Professor Kristina Lorenz (University of Würzburg)

Interfering with ERK dimerization and autophosphorylation as therapeutic strategy in heart failure

 

4th April

Dr Giancarlo Forte (King's College of London)

The different layers of mechanosensing in the failing heart

 

18th April 

Dr Gustavo Ramos (University Hospital Wurzburg)

Exploring the cardio-immune crosstalk across the full aging spectrum

 

2nd May

Dr Anna Zoccarato (King's College)

NRF2 activation in the heart induces glucose metabolic reprogramming and mediates cardioprotection via unregulation of the pentose phosphate pathway

 

9th May

Dr Juma El-Awaisi (University of Birmingham)

Getting to the heart of the matter: advancing cardiopulmonary disease research with in vivo and ex vivo imaging techniques

 

16th May

Dr Hiran Prag (University of Cambridge)

Targeting succinate metabolism to treat cardiac ischemia/reperfusion injury

 

30th May

Professor Pasquale Maffia (University of Glasgow)

Immune dysregulation in cardiovascular disease - from novel mechanisms to therapeutic targeting

 

13th June

Dr Marie Jost (UKE, Hamburg)

Unravelling the precise molecular pathomechanisms of how mutations PRKG1 cause thoratic aneurysm and dissection

 

27th June

Professor Norata Giuseppe Danilo (University of Milan)

Cholesterol and lipoprotein metabolism as immunometabolic checkpoints in the adaptive immune response

 

11th July

Dr Ingrid Dumitriu (University of Birmingham)

Interrogating inflammatory pathways in patients with cardiovascular disease to identify novel targets for personalised interventions

 

5th September

Professor Jared Rutter (HHMI, University of Utah School of Medicine)

Metabolism, cellular decisions and the language that unites them

 

19th September

Ancheng Zheng (QMUL)

NRF3-mediated mitochondrial superoxide promotes cardiomyocyte apoptosis and impairs cardiac functions by suppressing pitx2

 

3rd October

Associate Professor Pieter-Jan Guns (University of Antwerp)

Physical exercise during experimental myocarditis in mice, raising a red flag?

 

17th October

Professor Allan Lawrie (Imperial College London)

Unraveling layers of heterogeneity to reclassify pulmonary hypertension

 

14th November

Heartfelt Stories: why public engagement and involvement matters 

 

Upcoming Seminars and 2025 Dates

 

9th January

Professor Simon Lebek (University of Regensburg)

Silencing common pathomechanisms with gene editing

 

23rd January

Dr Xuan Li (University of Cambridge)

Regulation of microtubule function in cardiovascular disease

 

6th February

Dr Meritxell Nus (University of Cambridge)

TBA

 

20th February

Professor David Lefer (Cedars-Sinai)

TBA 

 

6th March 

Dr Andrew Lewis (University of Oxford)

Imaging, proteomic and metabolic characterisation of exercise responses across the spectrum of HFpEF

 

20th March

Dr Adjanie Patabendige (Edge Hill University)

TBA

 

27th March

Associate Professor Dominic Del Re (Rutgers New Jersey Medical School)

TBA

 

3rd April

Dr Thomas Eykyn (King's College London)

Dysregulated metabolism viewed through the lens of multinuclear NMR in living systems

 

10th April

TBA

 

22nd May

TBA

 

29th May

TBA

 

12th June

TBA

 

26th June 

TBA

 

10th July

TBA

 

24th July

TBA

Archive

Back to top